Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marc Decramer

Showing results (61-70 of 201) with videos related to

Pageof 21
Sort By:
Respiratory Care|September 13, 2013
Pathological breathing patterns after pneumococcal rhombencephalitisSophie Muyldermans, Bart Vrijsen, Marc Decramer, et al.
Medical & Biological Engineering & Computing|October 1, 2014
Modelling the dynamics of expiratory airflow to describe chronic obstructive pulmonary diseaseMarko Topalovic, Vasileios Exadaktylos, Marc Decramer, et al.
Antimicrobial Agents and Chemotherapy|April 6, 2011
Consumption patterns and in vitro resistance of Streptococcus pneumoniae to fluoroquinolonesSteven Simoens, Jan Verhaegen, Pascal van Bleyenbergh, et al.
International Journal of Radiation Oncology, Biology, Physics|March 15, 2011
Changes in pulmonary function up to 10 years after locoregional breast irradiationKatrien Erven, Caroline Weltens, Kristiaan Nackaerts, et al.
American Journal of Respiratory and Critical Care Medicine|January 24, 2009
Vitamin D beyond bones in chronic obstructive pulmonary disease: time to actWim Janssens, An Lehouck, Claudia Carremans, et al.
Respiratory Medicine|December 11, 2012
Effects of long-acting bronchodilators in COPD patients according to COPD severity and ICS useMarc Decramer, Ronald Dahl, Oliver Kornmann, et al.
Respiratory Research|August 8, 2012
Longitudinal inspiratory capacity changes in chronic obstructive pulmonary diseaseBartolome R Celli, Marc Decramer, Theodore Lystig, et al.
Respirology (Carlton, Vic.)|April 17, 2015
Using dynamics of forced expiration to identify COPD where conventional criteria for the FEV₁ /FVC ratio do not matchMarko Topalovic, Vasileios Exadaktylos, Marc Decramer, et al.
Trials|November 30, 2012
Eight-step method to build the clinical content of an evidence-based care pathway: the case for COPD exacerbationCathy Lodewijckx, Marc Decramer, Walter Sermeus, et al.
Chest|October 22, 2011
Sensitization in medically unexplained dyspnea: differential effects on intensity and unpleasantnessLi Wan, Linda Stans, Katleen Bogaerts, et al.
Pageof 21

Showing results (61-70 of 201) with videos related to

Sort By:
Pageof 21
Respiratory Care|September 13, 2013
Pathological breathing patterns after pneumococcal rhombencephalitisSophie Muyldermans, Bart Vrijsen, Marc Decramer, et al.
Medical & Biological Engineering & Computing|October 1, 2014
Modelling the dynamics of expiratory airflow to describe chronic obstructive pulmonary diseaseMarko Topalovic, Vasileios Exadaktylos, Marc Decramer, et al.
Antimicrobial Agents and Chemotherapy|April 6, 2011
Consumption patterns and in vitro resistance of Streptococcus pneumoniae to fluoroquinolonesSteven Simoens, Jan Verhaegen, Pascal van Bleyenbergh, et al.
International Journal of Radiation Oncology, Biology, Physics|March 15, 2011
Changes in pulmonary function up to 10 years after locoregional breast irradiationKatrien Erven, Caroline Weltens, Kristiaan Nackaerts, et al.
American Journal of Respiratory and Critical Care Medicine|January 24, 2009
Vitamin D beyond bones in chronic obstructive pulmonary disease: time to actWim Janssens, An Lehouck, Claudia Carremans, et al.
Respiratory Medicine|December 11, 2012
Effects of long-acting bronchodilators in COPD patients according to COPD severity and ICS useMarc Decramer, Ronald Dahl, Oliver Kornmann, et al.
Respiratory Research|August 8, 2012
Longitudinal inspiratory capacity changes in chronic obstructive pulmonary diseaseBartolome R Celli, Marc Decramer, Theodore Lystig, et al.
Respirology (Carlton, Vic.)|April 17, 2015
Using dynamics of forced expiration to identify COPD where conventional criteria for the FEV₁ /FVC ratio do not matchMarko Topalovic, Vasileios Exadaktylos, Marc Decramer, et al.
Trials|November 30, 2012
Eight-step method to build the clinical content of an evidence-based care pathway: the case for COPD exacerbationCathy Lodewijckx, Marc Decramer, Walter Sermeus, et al.
Chest|October 22, 2011
Sensitization in medically unexplained dyspnea: differential effects on intensity and unpleasantnessLi Wan, Linda Stans, Katleen Bogaerts, et al.
Pageof 21